NORCROSS, Ga., March 31, 2026 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31, 2025. Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, said “We are at an important juncture for the belapectin development program. During 2025, we made meaningful progress advancing the belapectin program and continuing our analysis of the NAVIGATE dataset in patients with MASH cirrhosis and portal hypertension. We are encouraged by the signals observed, including additional biomarkers from the NAVIGATE dataset, and remain focused on evaluating the data as we engage with regulators, potential partners, and leading experts to determine the optimal...

Completed End-of-Phase 2 meeting with the FDA; Company expects to provide a regulatory update in early 2Q 2026 and remains on track to initiate a Phase 3 study in chronic tetraplegia in mid-2026. Company expects to present clinical data from independent, blinded biomechanical gait analyses of the CONNECT SCI study in 2Q 2026, providing additional evidence with the potential to further support the systemic biological effect of NVG-291, differentiating genuine neural recovery from compensatory movement. Company expects to expand NVG-291 into complementary clinical indications, as informed by established preclinical efficacy, with prioritization expected to be announced by mid-2026. Successful Nasdaq listing and continued growth of leadership team supports the Company’s emergence as a leader in the development of neuroreparative therapeutics.VANCOUVER,...

FY 2025 net product revenues increased 65% to $1,005,000 Current shelf capacity exhausted after raise of $4 million through an ATM facilityWASHINGTON, March 31, 2026 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, reported today its financial results for the 2025 fiscal year ended December 31, 2025. Financial Highlights for the Fiscal Year Ended December 31, 2025:Net product revenues increased 65% from $607.6 thousand in 2024 to $1.0 million in 2025, driven by rising sales, price increases, and fewer returns. The Company achieved a gross profit of approximately $223.8 thousand in 2025, compared with approximately $222.8 thousand in 2024. Gross profit remained relatively stable despite inventory write-offs...

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, March 31, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announces its financial and operating results for the full year 2025:Commercial traction: The Company initiated the commercialization of its first technology platform and sold 117 ARC-EX® Systems, demonstrating strong commercial traction for its groundbreaking external spinal stimulation system. ARC-EX was sold to more than 80 US rehabilitation clinics by the end of the year. Regulatory milestones: The...

MONTREAL, March 30, 2026 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX:PYR) (OTCQX:PYRGF) (FRA:8PY1), a leader in ultra-high temperature processes & engineering innovation, and a plasma-based technology provider to heavy industry & defense, today announces its financial and operating results for the fourth quarter and full year ended December 31, 2025. “In 2025, despite exceptionally volatile geopolitical, tariff, supply chain, and energy supply dynamics that caused uncertainty across various heavy industry sectors and regions, we continued to press forward to achieve notable progress on several fronts,” said P. Peter Pascali, President and CEO of PyroGenesis Inc. “While our financial performance in 2025 did not meet our expectations, as we move into 2026 we are focused on converting our technological...

TORONTO, March 30, 2026 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCID: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) today reported its financial results for the fiscal year ended December 31, 2025. All figures are expressed in United States dollars, unless otherwise indicated. Carbon Streaming Chief Executive Officer Marin Katusa stated: “In the fourth quarter of 2025, Carbon Streaming continued to strengthen its financial position and focus on maximizing value from its existing assets. During the quarter, we achieved positive operating cash flow, while we also recorded a net increase in cash during the year, reflecting the success of our cost reduction initiatives and continued progress in generating cash through the optimization of our portfolio. During the last year and into this year, we also...

VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”, or the “Company”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB. V), today announced its financial results for the three months and year ended December 31, 2025. All amounts presented in this news release are in United States dollars (“U.S. dollars”) unless otherwise indicated. 2025 FOURTH QUARTER HIGHLIGHTSSame Property ADR(1) was $137 for the fourth quarter of 2025 an increase of 1.5% compared to the same period of 2024. Same Property Occupancy(1) was 68.9% for the fourth quarter of 2025, a decrease of 100 bps compared to the same period of 2024. Same Property RevPAR(1) was $94 for the fourth quarter of 2025, consistent with the same period of 2024. Same property NOI was $7.2 million for the fourth quarter of 2025, a decrease...

Key Fiscal Year reported data points:Revenue of $60.7 million, +2.1% vs. 2024 GAAP net income (loss) from continuing operations of $2.5 million vs. $4.2 million in 2024 GAAP net income (loss) from continuing operations per fully diluted share of $0.046 vs. $0.081 in 2024 Non-GAAP adjusted EBITDA of $2.4 million vs. $4.1 million in 2024. Subsequent Events: Final close of PA facility, full payoff of note associated with facility.Key Fourth Quarter data points:Revenue of $13.3 million, down 18.1% vs. Q4 2024 GAAP net income from continuing operations of $797 thousand vs. $685 thousand in Q4 2024 GAAP net income from continuing operations per fully diluted share of $0.015 vs. $0.013 in Q4 2024 Non-GAAP adjusted EBITDA of $718 thousand vs. $1.3 million in Q4 2024Subsequent Event:On March 6, 2026, Innovative Food Properties, LLC completed...

MIAMI and NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) — Siebert Financial Corp. (NASDAQ: SIEB) (“Siebert”), a diversified provider of financial services, today announced financial results for the year ended December 31, 2025. 2025 Financial and Operational Highlights*Revenue increased 12% to $94.2 million, compared to $83.9 million in 2024. Stock borrow / stock loan revenue increased by 51% to $29.0 million, compared to $19.2 million in 2024. Operating income decreased to $5.6 million compared to $17.5 million in 2024, primarily due to the buildout of new business lines and investments in technology initiatives. Retail customer net worth increased 9% to $19.5 billion, compared to $18.0 billion at the end of 2024.2025 Business HighlightsIn the second quarter of 2025, Siebert made strategic investments totaling $2.4 million in...

AleAnna, Inc. reports positive Adjusted EBITDA[1] and net income for the third consecutive quarter DALLAS, March 30, 2026 (GLOBE NEWSWIRE) — AleAnna, Inc. (“AleAnna” or “the Company”) (NASDAQ: ANNA) today announced financial and operational results for the fourth quarter and full year of 2025. AleAnna reported full year net income of $2.9 million and Adjusted EBITDA[1] of $6.6 million. Fourth Quarter 2025 Results and Recent Company Highlights:AleAnna generated $0.3 million of net income and $3.0 million of Adjusted EBITDA in the fourth quarter, driven by strong production at the Longanesi field, generating $9.1 million of revenue in the quarter. AleAnna closed the period with a strong cash position of $31.8 million, supporting ongoing development activity and future strategic initiatives. Gradizza Concession secured which represents...